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CRYOSURGERY: ITS ROLE IN LIVER TUMOURS
ABSTRACT
Ravikumar, T.S., Kane, R., Cady, B., Jenkins, R., Clouse, M. and Steele, G., Jr.
(1991) A 5-year study of cryosurgery in the treatment of liver tumours. Archives of
Surgery; 126: 1520-1524.
This report summarizes our 5-year experience with cryosurgery for in situ ablation
of liver tumors. The liver was exposed with laparotomy, and the tumors were
subjected to two freeze-thaw cycles using liquid nitrogen delivered by insulated
probes; cryoablation was monitored with intra-operative ultrasonography. Tumor
markers and computed tomography evaluated tumor response during long-term
follow-up. From 1985 to 1990, 32 patients (19 men and 13 women) were entered into
this study. The histologic characteristics of the tumors were as follows" colorectal, 24
patients; hepatoma, three patients; neuroendocrine, two patients; and others, three
patients. After a follow-up period of 5 to 60 months (median follow-up, 24 months),
nine patients (28%) remained disease free, 11 patients (34%) were alive with disease,
and 12 patients (38%) died. The patterns of failure included liver and extrahepatic
disease in 54% of cases, liver disease only in 32% of cases, and extrahepatic disease
only in 14% of cases. In patients with "liver only" failure, recurrence at the
treatment site occurred in three patients (9%). This study establishes the long-term
effectiveness of cryosurgery in the treatment of primary and metastatic liver tumors.
(Arch. Surg. 1991; 126: 1520-1524)
PAPER DISCUSSION
KEY WORDS" Liver secondary carcinoma, cryosurgery
This paper reports the use of cryosurgery in the treatment of liver tumours and
raises two interesting issues: the value of cryodestruction as a technique for
destroying malignant tumours in general and more specifically for the management
of liver tumours.
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Cryosurgery has been used successfully for many years for tumour destruction in
surgical fields. Perhaps it has been used most successfully and enthusiastically for
the treatment of skin cancers. Basal cell carcinomas and some epitheliomas can be
treated with a reported cure rate of 97.6%. These results are comparable to surgical
excision and radiotherapy1’2. There are two main advantages of cryodestruction
over other treatments for skin lesions: frequently only one outpatient attendance is
needed and healing is almost perfect, except around the eyes, with minimal
scarring. Sometimes the only indication that any treatment has occurred is a
residual area of depigmentation; this is often more marked in dark skinned
patients.
Some studies report the value of the technique as a palliative symptomatic
method of dealing with large inoperable tumours such as ulcerating carcinomas of
the rectum. It has been shown to be of value in palliating many of the unpleasant
symptoms of these lesions in patients for whom surgical resection was not possible3.
Although its value has been investigated as a method for managing prostatic
tumours, it fell into disrepute due to complications, especially urethrorectal
fistulas. However in a recent report to the Society of Cryobiology, Dr Jeffrey
Cohen and co-workers from Allegheny General Hospital, Pittsburgh point out that
by refining the technique they observe few local complications and their early data
suggests it is effective in destroying malignant tissue4.
At the same meeting Dr Marcove and colleagues from Memorial Sloan Kettering
Cancer Center report some favourable results for the technique in the management
of bone malignancies5.
Cryosurgery is a simple technique and there are several liquid nitrogen cooled
cryosurgical machines on the market. There has been some engineering develop-
ment of the probes recently and some are now fine enough and sufficiently
insulated to be inserted into tumours. Most evidence suggests that two freeze-thaw
cycles using a liquid nitrogen cooled probe will provide total destruction of any
cells. Since it is so straight forward a procedure it is surprising that it does not
attract more attention from clinicians.
Unfortunately most enthusiasts who advocate using the technique fail to carry
out randomised studies designed to compare prospectively the results of cryosur-
gery and more conventional treatments of the same tumour.
This is the case in the management of liver tumours and this paper by Ravikumar
and colleagues is another example. It set out to study the value of cryosurgery for
treating patients with a mixed bag of primary and secondary liver tumours (mostly
secondary) not suitable for surgical resection. The authors describe clearly how
they use ultrasound guidance to watch in real time the growth of the ice ball
through the malignant lesion. They and others6’7 have shown previously that this is
a very practical and effective technique for ensuring all the tumour is frozen. In this
paper they show that they are able to totally destroy some malignant lesions in the
liver by local freezing. However although the overall results of treatment in this
group of patients, who were not amenable to surgery, were encouraging, there
were no controls against which the effect of the cryosurgical treatment could be
judged. By very nature of the fact that the patients treated were "inoperable" the
tumours must have been quite advanced.
The subsequent discussion of this paper by others at the meeting to which it was
presented centred on the treatment of these advanced and inoperable liver
tumours. However in this situation the success or failure of local treatment is oftenHPB INTERNATIONAL 91
determined by progression of untreated metastatic disease at other sites. Dr Gage
says, "Findings of some reports have suggested that the survival of patients with
metastatic carcinoma is extended by cryosurgical treatment. Whether or not this is
true will require additional study’’2.
Certainly it seems that cryodestruction is a valuable therapeutic modality for
treating liver cancers. It is safe and in one study of 60 patients with primary liver
cancer treated by cryosurgery there were no complications of bile leakage,
bleeding, infection or operative death8.
I believe the next step now is to design a prospective study of the treatment of not
inoperable lesions but small and operable tumours. It should compare surgical
resection, cryotherapy and the other technique reported to destroy liver tumours,
absolute alcohol injection9. To make such a study really meaningful it would be
necessary, too, to include an untreated limb. However the ethics of this would need
careful discussion. As a result of such a study we would really gain some idea of the
value of cryodestruction in relation to the natural history of the disease and in
comparison with other treatment modalities.
Professor K. E. F. Hobbs
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